The Indian government is set to deploy Smart Doctor, an AI-powered Clinical Decision Support System (CDSS) developed by AIIMS New Delhi, across nearly 70,000 public and private hospitals under the Ayushman Bharat Digital Mission (ABDM). This rule-based digital assistant will aid clinicians in diagnosing and treating non-communicable diseases like diabetes and hypertension, providing evidence-based recommendations while ensuring doctors retain final authority.
Glimpse:
Announced in late December 2025, the National Health Authority (NHA) has directed states and UTs to activate the CDSS module in hospital software immediately. The tool analyzes patient history to suggest treatment plans, optimal drugs/dosages, and flags contraindications aiming to standardize care quality, reduce misdiagnoses, and serve as an educational aid in resource-constrained settings. Non-ABDM-compliant systems must upgrade, with central technical support provided.
In a landmark push to leverage AI for equitable healthcare, the Indian government is rolling out an AI-powered Clinical Decision Support System (CDSS) named Smart Doctor across approximately 70,000 hospitals nationwide. This initiative, driven by the National Health Authority (NHA) under the Ayushman Bharat Digital Mission (ABDM), seeks to standardize treatment protocols, minimize medical errors, and enhance outcomes for non-communicable diseases (NCDs).
Developed by the All India Institute of Medical Sciences (AIIMS) New Delhi, Smart Doctor operates as a non-overriding digital assistant for clinicians. Using a rule-based framework, it cross-references patient symptoms, medical history, and protocols against a standardized database to deliver evidence-based insights.
Key functionalities include:
Recommending optimal treatment plans tailored to NCDs like diabetes and hypertension.
Suggesting appropriate drug selections and dosages.
Flagging potential drug contraindications and adverse interactions for safer prescribing.
The NHA has issued directives to all states and Union Territories to implement the tool promptly, instructing hospital software vendors to “switch on” the CDSS module. Facilities on non-ABDM-approved platforms must upgrade for seamless integration, with the Centre extending technical assistance to ensure smooth adoption.
This deployment builds on India’s maturing digital health ecosystem, where tools like this can act as educational aids especially in high-volume or underserved areas while empowering doctors with real-time, reliable support.
Industry leaders have welcomed the move, noting its potential to bridge gaps in care consistency amid rising NCD burdens.
“CDSS supports doctors it doesn’t replace them. By strengthening decisions in non-communicable diseases, it reduces errors while keeping clinical judgment in control.”
By
HB Team
